Compare Davita Inc (DVA) vs T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs T-Rex 2X Inverse MSTR Daily Target ETF — how do they compare? Davita Inc trades at $178.89 (market cap $11.29B), while T-Rex 2X Inverse MSTR Daily Target ETF trades at $2.63 (market cap $94.46M). The key difference: Davita Inc is far larger — about 119.5× T-Rex 2X Inverse MSTR Daily Target ETF's market cap, and Davita Inc is trading nearer its 52-week high, T-Rex 2X Inverse MSTR Daily Target ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Davita Inc for 113 Days and T-Rex 2X Inverse MSTR Daily Target ETF for 8 Days on average.
| DVA | MSTZ | |
|---|---|---|
Market Cap | $11.29B | $94.46M |
Volume | 582,204 | 104,717,733 |
Sector | Health | Leveraged / Inverse |
52-Week High | $240.96 | $27.92 |
52-Week Low | $103.87 | $2.29 |
Typical Hold Time | 113 Days | 8 Days |
Enterprise Value | $24.01B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $176.78, down 2.01% today, with a bearish technical signal and neutral oscillators. The company shows strong earnings beats in recent quarters with Q2 2026 EPS of $4.02 beating expectations of $3.88. Revenue growth continues from $13.64B in 2025 to projected $14.0B in 2026, though net margins have fluctuated. Recent partnership expansion with Humana for value-based kidney care represents significant business development.
DVA presents a mixed outlook with 43% analyst buy ratings and a $235.67 price target suggesting 33% upside. However, high debt levels (65.55% debt-to-asset ratio) and regulatory risks in healthcare weigh on fundamentals. The stock's current valuation at P/E 15 and P/S 0.88 appears reasonable relative to earnings growth potential, making it attractive for value investors despite near-term bearish technicals.
MSTZ is trading at $2.66, up 13.43% today, but technical indicators signal a bearish trend with moving averages and overall momentum favoring sellers. Key financial ratios such as P/E, P/S, and P/B are unavailable, limiting fundamental clarity. The stock's recent mention in ETF Trends (September 15, 2026) highlights its inclusion in leveraged ETF discussions, though this reflects market volatility rather than company-specific news.
The outlook is cautious due to weak technicals and missing fundamental data. Risks include high volatility from leveraged ETF exposure and lack of transparent financials. Investors should seek updated SEC filings for earnings and valuation metrics before considering a position, as current data gaps hinder a reliable assessment of growth or stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About T-Rex 2X Inverse MSTR Daily Target ETF
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →
